Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  RedHill Biopharma Ltd       IL0011223810

REDHILL BIOPHARMA LTD

  Report  
 SummaryChartsNewsCalendarCompanyFinancialsRevisions 
Financials (USD)
Sales 2019 13,2 M
EBIT 2019 -39,1 M
Net income 2019 -39,1 M
Debt 2019 12,1 M
Yield 2019 -
Sales 2020 -
EBIT 2020 -
Net income 2020 -
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020 -
Capi. / Sales2019 18,4x
Capi. / Sales2020 -
Capitalization 231 M
More Financials
Company
Redhill Biopharma Ltd, is an Israel-based specialty biopharmaceutical company. The Company focuses on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer. It... 
More about the company
Latest news on REDHILL BIOPHARMA LTD
04/05REDHILL BIOPHARMA : to Present at Three Conferences in April
AQ
04/04RedHill Biopharma to Present at Three Conferences in April
GL
03/18RedHill Biopharma to Present at the BIO-Europe Spring 2019 Conference
GL
03/05REDHILL BIOPHARMA : Announces New European and Japanese Patents for Talicia
AQ
03/05REDHILL BIOPHARMA : Announces New European and Japanese Patents for Talicia
AQ
03/04RedHill Biopharma Announces New European and Japanese Patents for Talicia®
GL
02/26RedHill Biopharma Provides Full-Year 2018 Financial Results and Operational H..
GL
02/21RedHill Biopharma to Host Full-Year 2018 Financial Results Conference Call on..
GL
02/20RedHill Biopharma Strengthens Management Team with Appointment of Rick D. Scr..
GL
02/19REDHILL BIOPHARMA : to Present at the 8th Annual SVB Leerink Healthcare Conferen..
AQ
More news
Sector news : Bio Therapeutic Drugs
04/16GILEAD SCIENCES : Insitro to Collaborate on Nonalcoholic Steatohepatitis
DJ
04/15PATRICK THOMAS : Novartis Files Application for Macular Degeneration Treatment
DJ
04/12GILEAD SCIENCES : Novo Nordisk Plan NASH Collaboration
DJ
04/08GSK wins U.S. nod for two-drug HIV combination
RE
04/08Sanofi, Alnylam Complete Research Phase of Rare Disease Alliance
DJ
More sector news : Bio Therapeutic Drugs
Chart REDHILL BIOPHARMA LTD
Duration : Period :
RedHill Biopharma Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
EPS Revisions
Managers
NameTitle
Dror Ben-Asher Chairman & Chief Executive Officer
Gilead Raday Chief Operating Officer
Micha Ben-Chorin Chief Financial Officer
Reza Fathi Senior Vice President-Research & Development
Ira N. Kalfus Medical Director
Sector and Competitors
1st jan.Capitalization (M$)
REDHILL BIOPHARMA LTD53.45%231
GILEAD SCIENCES-1.09%80 255
VERTEX PHARMACEUTICALS1.70%42 991
REGENERON PHARMACEUTICALS-10.57%35 789
GENMAB5.11%10 423
SAREPTA THERAPEUTICS INC4.27%8 594